Mannose-modified tobacco mosaic virus-mediated macrophage regulation inhibits pulmonary fibrosis progression.
A mannose-modified tobacco mosaic virus nanoparticle is developed, which targets and reprograms profibrotic macrophages to inhibit IPF and establishes plant viral nanoparticles as a macrophage reprogramming strategy with therapeutic potential for organ fibrosis.